Please wait...

Learn

Finding accredited CPD

Lung cancer: progress with prognosis and the changing state of play

Description

Lung cancer is the second most common cancer in the world, accounting for 11.4% of all cancers, but with 18.0% of total cancer-related deaths, it is the leading cause of cancer death.

In Australasia, the incidence of lung cancer varies between 19.1 and 42.1 per 100,000 population, with the strongest risk factors historically being increasing age and tobacco smoke exposure.

While tobacco control remains the mainstay of reducing the impact of lung cancer for decades to come, there have been recent highly significant advances in lung cancer diagnostic approaches and treatment regimens which are beginning to affect outcomes for Australians with lung cancer.

This MJA perspective shares more.


Learning Outcomes

  1. Explain key components of the perspective
  2. List main findings
  3. Recognise changes in the approach to lung cancer treatments and outcomes.

Details

Authors: Fraser J Brims, Annette McWilliams, Susan V Harden and Ken O'Byrne

Article Type: Perspective

 

Provided by


CPD Activity Details
Topic
Oncology, Diagnostic Techniques, Procedures and Imaging, Neoplasms
CAPE Aspects
_
Effective Year

Educational Activities (EA) - 1.0

Reviewing Performance (RP) - 0.0

Measuring Outcomes (MO) - 0.0

You have to log in to see the content of this module.

*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)